Rifaximin Alters Intestinal Microbiota and Prevents Progression of Ankylosing Spondylitis in Mice

Recently, accumulating evidence has suggested that gut microbiota may be involved in the occurrence and development of ankylosing spondylitis (AS). It has been suggested that rifaximin have the ability to modulate the gut bacterial communities, prevent inflammatory response, and modulate gut barrier...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Front Cell Infect Microbiol
मुख्य लेखकों: Yang, Lianjun, Liu, Bin, Zheng, Junchi, Huang, Jincheng, Zhao, Qinghao, Liu, Jinshi, Su, Zhihai, Wang, Min, Cui, Zhifei, Wang, Tingxuan, Zhang, Weicong, Li, Qingchu, Lu, Hai
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Frontiers Media S.A. 2019
विषय:
Cellular and Infection Microbiology
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6409347/
https://ncbi.nlm.nih.gov/pubmed/30886835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcimb.2019.00044
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन